Frank Rimerman Advisors LLC Increases Stake in Walgreens Boots Alliance, Inc. (NASDAQ:WBA)

Frank Rimerman Advisors LLC grew its position in Walgreens Boots Alliance, Inc. (NASDAQ:WBA) by 6.6% during the 1st quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm owned 17,682 shares of the pharmacy operator’s stock after acquiring an additional 1,094 shares during the quarter. Frank Rimerman Advisors LLC’s holdings in Walgreens Boots Alliance were worth $198,000 at the end of the most recent reporting period.

Several other hedge funds and other institutional investors have also made changes to their positions in WBA. Two Sigma Advisers LP increased its stake in Walgreens Boots Alliance by 186.3% in the 4th quarter. Two Sigma Advisers LP now owns 7,740,100 shares of the pharmacy operator’s stock worth $72,215,000 after buying an additional 5,036,300 shares during the period. Wealthquest Corp purchased a new position in Walgreens Boots Alliance in the 1st quarter worth about $38,457,000. National Bank of Canada FI increased its stake in Walgreens Boots Alliance by 1,223.1% in the 1st quarter. National Bank of Canada FI now owns 3,582,442 shares of the pharmacy operator’s stock worth $40,016,000 after buying an additional 3,311,682 shares during the period. Two Sigma Investments LP increased its stake in Walgreens Boots Alliance by 101.2% in the 4th quarter. Two Sigma Investments LP now owns 4,595,507 shares of the pharmacy operator’s stock worth $42,876,000 after buying an additional 2,311,806 shares during the period. Finally, Los Angeles Capital Management LLC purchased a new position in Walgreens Boots Alliance in the 1st quarter worth about $19,760,000. Hedge funds and other institutional investors own 58.59% of the company’s stock.

Wall Street Analysts Forecast Growth

Several research analysts recently commented on the stock. Wall Street Zen assumed coverage on shares of Walgreens Boots Alliance in a research note on Wednesday, May 21st. They issued a “hold” rating on the stock. UBS Group reaffirmed a “neutral” rating on shares of Walgreens Boots Alliance in a research note on Thursday, June 26th. Finally, Morgan Stanley reaffirmed an “underweight” rating on shares of Walgreens Boots Alliance in a research note on Thursday, June 26th. Four analysts have rated the stock with a sell rating, seven have issued a hold rating and two have issued a buy rating to the stock. Based on data from MarketBeat, the company presently has a consensus rating of “Hold” and an average target price of $10.59.

Walgreens Boots Alliance Stock Down 0.7%

Shares of Walgreens Boots Alliance stock opened at $11.86 on Tuesday. Walgreens Boots Alliance, Inc. has a 1 year low of $8.08 and a 1 year high of $13.25. The stock has a market cap of $10.27 billion, a price-to-earnings ratio of -1.63, a PEG ratio of 1.40 and a beta of 0.80. The company has a debt-to-equity ratio of 0.96, a current ratio of 0.60 and a quick ratio of 0.32. The firm’s 50-day moving average is $11.50 and its two-hundred day moving average is $11.10.

Walgreens Boots Alliance (NASDAQ:WBA) last released its quarterly earnings results on Thursday, June 26th. The pharmacy operator reported $0.38 earnings per share for the quarter, beating analysts’ consensus estimates of $0.34 by $0.04. Walgreens Boots Alliance had a negative net margin of 4.07% and a positive return on equity of 17.66%. The business had revenue of $38.99 billion for the quarter, compared to analysts’ expectations of $36.72 billion. During the same period last year, the business earned $0.63 EPS. The company’s revenue was up 7.2% compared to the same quarter last year. As a group, research analysts expect that Walgreens Boots Alliance, Inc. will post 1.6 earnings per share for the current fiscal year.

Walgreens Boots Alliance Company Profile

Walgreens Boots Alliance, Inc operates as a healthcare, pharmacy, and retail company in the United States, the United Kingdom, Germany, and internationally. It operates through three segments: U.S. Retail Pharmacy, International, and U.S. Healthcare. The U.S. Retail Pharmacy segment engages in operation of the retail drugstores, health and wellness services, specialty, and home delivery pharmacy services, which offers health and wellness, beauty, personal care and consumables, and general merchandise.